Salute e Benessere

Inside information: Bioretec initiates change negotiations to enhance…

The change negotiations will commence on 19 November 2025 and will last for an estimated 2 weeks. The change negotiations will commence on19 November 2025and will last for an estimated 2 weeks. A total of 15 employees from Bioretec's staff inFinlandare included in the scope of the negotiations. The negotiations may impact the employment terms of up to eight individuals. Topics under change negotiations include potential termination of employment, unilateral changes to employment...
PR Newswire
12/11/2025

EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2…

Globally, there are approximately 2.3 million breast cancer patients, of which about 20% are diagnosed with HER2-positive disease. The Trastuzumab and Pertuzumab combination therapy has become the current standard of care for these patients. Recent studies also suggest that Pertuzumab combined with Trastuzumab deruxtecan (Enhertu®) may become the new first-line treatment for HER2-positive metastatic breast cancer, indicating strong potential for future market expansion of EG1206A. In addition to…
PR Newswire
12/11/2025

Swastik Wellbeing Sanctuary, India Honoured with the Global Emergence Wellness…

The award was presented by Ms. Uma Kumaran, Member of Parliament, United Kingdom, during a ceremony hosted by Crescent Meditours (UK) Ltd. The recognition highlights Swastik Wellbeing's global commitment to reimagining wellness as a multidimensional pursuit that unites traditional Indian healing sciences with modern therapeutic innovations. The award was presented by Ms. Uma Kumaran, Member of Parliament,United Kingdom, during a ceremony hosted by Crescent Meditours (UK) Ltd. The recognition...
PR Newswire
12/11/2025

New Study Uncovers Key Advances in Skin Longevity Research

Oripeptide-3 combines three purified peptides to boost cell energy, antioxidant protection and collagen production. It increases cell energy, reduces DNA and protein damage, and reactivates skin's defences, improving firmness, elasticity and wrinkles. Oripeptide-3 combines three purified peptides to boost cell energy, antioxidant protection and collagen production. It increases cell energy, reduces DNA and protein damage, and reactivates skin's defences, improving firmness, elasticity and ...
PR Newswire
12/11/2025

Millennials at highest risk of missing crucial cervical cancer screenings, finds…

"Millennials are often said to be the 'have it all generation,' juggling careers, caregiving, and societal expectations. Yet, they tend to put themselves last," said Joanna Sickler, Vice-President, Health Policy and External Affairs at Roche Diagnostics. "The research shows that millennials are disproportionately failing to prioritise cervical screening, because of a mix of emotional, logistical, and societal pressures. It's critical to design solutions like self-sampling that…
PR Newswire
12/11/2025

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3…

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN ®Peanut Patch in Peanut Allergic Children Aged 4-7 YearsCompany remains on track for VITESSE topline data in Q4 of this year DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced that the last patient visit has been completed in the Company’s Phase 3 VITESSE clinical...
Nasdaq GlobeNewswire
12/11/2025

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of…

BOSTON and LONDON, Nov.11, 2025(GLOBE NEWSWIRE) --Centessa Pharmaceuticals plc(Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $21.50 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $250 million, before deducting underwriting discounts and...
Nasdaq GlobeNewswire
12/11/2025

Antibody-Mediated Rejection Market Set to Expand Significantly During the…

Antibody-mediated Rejection Market Summary Antibody-mediated Rejection Market Summary Discover the antibody-mediated rejection new treatment @New Treatments for Antibody-mediated Rejection Key Factors Driving the Growth of the Antibody-mediated Rejection Market Rising Number of Transplants and Transplant Candidates The rising number of organ transplants has driven a parallel increase in AMR cases, highlighting the need for better diagnostics, closer monitoring, and...
PR Newswire
11/11/2025

NANOBIOTIX to Participate in Jefferies London Healthcare Conference

PARIS and CAMBRIDGE, Mass., Nov.11, 2025(GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “ Company ”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in a fireside chat at the following conference: Jefferies London Healthcare ConferenceDate: Monday, November 17, 2025 Time: 3pm GMT / 10am...
Nasdaq GlobeNewswire
11/11/2025

Centessa Pharmaceuticals Announces Proposed Public Offering of American…

BOSTON and LONDON, Nov.11, 2025(GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs offered in the public offering. The...
Nasdaq GlobeNewswire
11/11/2025

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%…

NEWS RELEASERECORDATIFIRSTNINEMONTHS2025RESULTS: REVENUE +12.2%, EBITDA (1) +11.8%, ADJUSTED NET INCOME (2) +10.7%; ISTURISAPEAKSALESESTIMATEDOUBLEDTOGREATERTHAN€1.2BILLION Consolidated net revenue of € 1,956.2 million in the first nine months of 2025, +12.2% or +8.1% on a like-for-like basis(3) and at constant exchange rates (CER)EBITDA(1)of€743.9million,+11.8%,marginonrevenueof38.0%Adjustednet...
Nasdaq GlobeNewswire
11/11/2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference in…

About Waters Corporation About Waters Corporation Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in...
PR Newswire
11/11/2025

Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% -…

Request or download a free sample copy of this report: Interventional Oncology Market Request or download a free sample copy of this report:Interventional Oncology Market The industry is responding to the urgent need for effective cancer treatments through active strategic initiatives and significant investment. Companies are dedicated to developing advanced solutions to improve patient care; for example, Terumo launched a dedicated global therapeutic interventional oncology team to...
PR Newswire
11/11/2025

Medical Device Outsourcing Market to hit $386.08 Billion by 2033 - Grand View…

The market is classified by service into contract manufacturing, quality assurance, regulatory affairs, product design & development, product testing & sterilization, product implementation, product upgrade, and product maintenance services, with contract manufacturing services accounting for the largest revenue share at 55.1% in 2024. This dominance is fueled by market players striving to reduce costs due to shrinking profit margins, which involves implementing shift work to curtail…
PR Newswire
11/11/2025

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 11 November, Mr Bob Sutcliffe, the Chairman, purchased 50,000 Ordinary Shares in the Company at a price of 1.30p per share.Following this transaction Mr Sutcliffe and his wife’s...
Nasdaq GlobeNewswire
11/11/2025

Meet Raccoon 2 SE on Kickstarter -- Bringing AI-Powered Mowing to Small Gardens

Forget the hassle of boundary wires or complicated RTK installations. With Raccoon 2 SE, users can start mowing straight out of the box. No wiring, no setup, no stress. Just press mow and let the Raccoon 2 SE take care of the rest. Forget the hassle of boundary wires or complicated RTK installations. With Raccoon 2 SE, users canstart mowing straight out of the box. No wiring, no setup, no stress. Just press mow and let the Raccoon 2 SE take care of the rest. "True to its "Just Press...
PR Newswire
11/11/2025

Molecular Spectroscopy Market to Reach $6.4 billion, Globally, by 2034 at 5%…

Request Sample of the Report on Molecular Spectroscopy Market Forecast 2034 - https://www.alliedmarketresearch.com/request-sample/A34944 Request Sample of the Report on Molecular Spectroscopy Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A34944 Market Introduction The molecular spectroscopy market encompasses a diverse range of analytical technologies used to study the interaction of electromagnetic radiation with matter, enabling precise...
PR Newswire
11/11/2025

Wastewater Surveillance Market worth $1.22 billion by 2030 with 6.7% CAGR |…

The range of testing capabilities has grown tremendously, driving the industry toward faster, more sensitive, and more affordable solutions. This includes progress in molecular diagnostics, next-generation sequencing (NGS), biosensors, multiplex PCR assays, and AI-powered data analytics for trend forecasting. The availability of portable, field-ready testing kits and cloud-based reporting platforms has further improved the speed and dependability of results. The range of testing capabilities...
PR Newswire
11/11/2025

Hair Salon Services Market to Reach $233.3 billion, Globally, by 2034 at 3.9%…

Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A325788 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A325788 Prime determinants of growth The hair salon services market is driven by factors such as rise in consumer focus on personal grooming and appearance, and influence of social media and celebrities. However, the availability of at-home and DIY skilled labor shortages and high...
PR Newswire
11/11/2025

Lexogen honored as one of Austria's Top Innovative Companies 2026 by Statista…

Supporting life science research and applications through innovation Supporting life science research and applications through innovation Founded inVienna, Austria, nearly two decades ago, Lexogen has always pursued a clear mission: tohelp scientists explore how genes workby developing advanced technologies to analyze RNA, the molecule that reveals gene activity. Theircomplete solutions for RNA and transcriptome analysis are used worldwideby researchers. These tools support both...
PR Newswire
11/11/2025

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 11 November 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated...
Nasdaq GlobeNewswire
11/11/2025

AC Immune to Present at the Jefferies 2025 London Healthcare Conference

AC Immune to Present at the Jefferies 2025 London Healthcare ConferenceLausanne, Switzerland, November 11, 2025 --AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies Global Healthcare Conference in London, taking place November 17-20, 2025.The fireside chat will take place...
Nasdaq GlobeNewswire
11/11/2025

Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion…

Xion is an innovative production company with its own patents based in Spain that has developed one of the world's first high-tech photobioreactor systems for the production of the nutrient-rich microalgae spirulina. Xion's groundbreaking, award-winning technology, with a cultivation method based on nature's own principles, sets a new standard for sustainable, efficient, and clean production and creates great opportunities for large-scale cultivation and production of all types of…
PR Newswire
11/11/2025

Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding…

EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations. EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated…
PR Newswire
11/11/2025
Altri  Comunicati